mounjaro patent expiration date tirzepatide patent expiry In weight loss battle, Novo and Lilly face growing offensive from licensed copies As Wegovy patent ends in

Tirzepatide, the active ingredient in Zepbound and Mounjaro, is part of new class of medications used to treat obesity and diabetes that have skyrocketed in popularity, driving shortages and leading some people to use versions made by compounding pharmacies

So, it's only natural that the next question on everyone's mind is: what's next

Vomiting, diarrhea, and constipation also occur

I cant believe how it has stopped the food noise and Im living life again

A., Vogt, R

The active ingredient is identical between Mounjaro and Zepbound, but the FDA indication and insurance coverage pathway differ, which matters if OSA is part of your medical picture